Pharma-Bio Serv Inc
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and pr… Read more
Pharma-Bio Serv Inc (PBSV) - Net Assets
Latest net assets as of October 2025: $11.91 Million USD
Based on the latest financial reports, Pharma-Bio Serv Inc (PBSV) has net assets worth $11.91 Million USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.65 Million) and total liabilities ($1.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.91 Million |
| % of Total Assets | 87.26% |
| Annual Growth Rate | 9.93% |
| 5-Year Change | -37.01% |
| 10-Year Change | -45.37% |
| Growth Volatility | 28.59 |
Pharma-Bio Serv Inc - Net Assets Trend (2007–2025)
This chart illustrates how Pharma-Bio Serv Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Pharma-Bio Serv Inc (2007–2025)
The table below shows the annual net assets of Pharma-Bio Serv Inc from 2007 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-10-31 | $11.91 Million | -13.13% |
| 2024-10-31 | $13.72 Million | -14.95% |
| 2023-10-31 | $16.13 Million | -2.60% |
| 2022-10-31 | $16.56 Million | -12.46% |
| 2021-10-31 | $18.91 Million | -16.74% |
| 2020-10-31 | $22.72 Million | +10.23% |
| 2019-10-31 | $20.61 Million | +1.70% |
| 2018-10-31 | $20.26 Million | -2.33% |
| 2017-10-31 | $20.75 Million | -4.87% |
| 2016-10-31 | $21.81 Million | -0.70% |
| 2015-10-31 | $21.96 Million | +7.08% |
| 2014-10-31 | $20.51 Million | +13.63% |
| 2013-10-31 | $18.05 Million | +40.19% |
| 2012-10-31 | $12.88 Million | +56.33% |
| 2011-10-31 | $8.24 Million | +62.48% |
| 2010-10-31 | $5.07 Million | +8.71% |
| 2009-10-31 | $4.66 Million | +15.08% |
| 2008-10-31 | $4.05 Million | +86.99% |
| 2007-10-31 | $2.17 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pharma-Bio Serv Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 413.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (October 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $10.53 Million | 88.41% |
| Other Components | $1.38 Million | 11.59% |
| Total Equity | $11.91 Million | 100.00% |
Pharma-Bio Serv Inc Competitors by Market Cap
The table below lists competitors of Pharma-Bio Serv Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
$4.02 Million |
|
IVF_INSPIRE IVF
BK:IVF
|
$4.03 Million |
|
New England Realty Associates LP
NYSE MKT:NEN
|
$4.03 Million |
|
Ilyda SA
AT:ILYDA
|
$4.03 Million |
|
Kohinoor Foods Limited
NSE:KOHINOOR
|
$4.02 Million |
|
Standard Industries Limited
NSE:SIL
|
$4.02 Million |
|
Healthy Choice Wellness Corp.
NYSE MKT:HCWC
|
$4.02 Million |
|
Home Pottery Public Company Limited
BK:HPT
|
$4.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pharma-Bio Serv Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 13,715,327 to 11,914,247, a change of -1,801,080 (-13.1%).
- Net loss of 100,463 reduced equity.
- Dividend payments of 1,719,918 reduced retained earnings.
- Share repurchases of 31,443 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-100.46K | -0.84% |
| Dividends Paid | $1.72 Million | -14.44% |
| Share Repurchases | $31.44K | -0.26% |
| Other Changes | $50.74K | +0.43% |
| Total Change | $- | -13.13% |
Book Value vs Market Value Analysis
This analysis compares Pharma-Bio Serv Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.92x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.60x to 0.92x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-10-31 | $0.80 | $0.48 | x |
| 2014-10-31 | $0.89 | $0.48 | x |
| 2015-10-31 | $0.95 | $0.48 | x |
| 2016-10-31 | $0.95 | $0.48 | x |
| 2017-10-31 | $0.90 | $0.48 | x |
| 2018-10-31 | $0.88 | $0.48 | x |
| 2019-10-31 | $0.90 | $0.48 | x |
| 2020-10-31 | $0.99 | $0.48 | x |
| 2021-10-31 | $0.82 | $0.48 | x |
| 2022-10-31 | $0.72 | $0.48 | x |
| 2023-10-31 | $0.70 | $0.48 | x |
| 2024-10-31 | $0.60 | $0.48 | x |
| 2025-10-31 | $0.52 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pharma-Bio Serv Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.12%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.15x
- Recent ROE (-0.84%) is below the historical average (14.66%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 87.72% | 11.73% | 1.69x | 4.41x | $1.68 Million |
| 2008 | 36.72% | 9.79% | 1.87x | 2.00x | $1.08 Million |
| 2009 | 11.47% | 4.66% | 1.91x | 1.29x | $68.70K |
| 2010 | 7.34% | 3.28% | 1.73x | 1.29x | $-134.90K |
| 2011 | 38.36% | 15.85% | 1.84x | 1.32x | $2.34 Million |
| 2012 | 36.40% | 16.04% | 1.86x | 1.22x | $3.40 Million |
| 2013 | 27.18% | 14.84% | 1.55x | 1.18x | $3.10 Million |
| 2014 | 11.77% | 8.76% | 1.19x | 1.13x | $362.57K |
| 2015 | 7.40% | 6.95% | 0.97x | 1.10x | $-571.48K |
| 2016 | -1.18% | -1.31% | 0.81x | 1.10x | $-2.44 Million |
| 2017 | -6.82% | -9.08% | 0.70x | 1.08x | $-3.49 Million |
| 2018 | 6.32% | 7.19% | 0.70x | 1.25x | $-746.63K |
| 2019 | 10.13% | 10.70% | 0.73x | 1.29x | $26.51K |
| 2020 | 9.03% | 9.51% | 0.72x | 1.32x | $-220.74K |
| 2021 | -11.05% | -10.39% | 0.84x | 1.26x | $-3.98 Million |
| 2022 | 6.08% | 5.19% | 0.94x | 1.25x | $-649.07K |
| 2023 | 8.12% | 7.72% | 0.85x | 1.23x | $-302.50K |
| 2024 | -5.67% | -8.18% | 0.58x | 1.19x | $-2.15 Million |
| 2025 | -0.84% | -1.12% | 0.66x | 1.15x | $-1.29 Million |
Industry Comparison
This section compares Pharma-Bio Serv Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pharma-Bio Serv Inc (PBSV) | $11.91 Million | 87.72% | 0.15x | $4.02 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |